The FDA and M-CERSI will host a public workshop, "Optimizing Pregnancy Registries." The purpose of the workshop is to discuss challenges in designing and implementing pregnancy registries and to consider innovative approaches to improve the design and conduct of pregnancy registries to inform the safety of drug and biological products during pregnancy. This public workshop is being held in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) program.